Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychiatr Serv 59:530-533, May 2008
doi: 10.1176/appi.ps.59.5.530
© 2008 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
Google Scholar
* Articles by Owens, D. C.
PubMed
* PubMed Citation
* Articles by Owens, D. C.
Related Collections
* Quality of Care, Practice Guidelines
* Research Design, Methodology
* Schizophrenia Spectrum Disorders
* Atypical Neuroleptics
* Conventional Neuroleptics
*Related Articles

Special Section on Implications of CATIE

What CATIE Did: Some Thoughts on Implications Deep and Wide

David Cunningham Owens, M.D., F.R.C.Psych.

The author discusses five lessons that can be learned from the seminal results of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE). The lessons extend beyond practice implications to fundamental questions about how psychopharmacology studies are conducted and how results are interpreted and given relevance in regard to prescribing. The author recounts the history of the term "atypical" and how it came to be understood in the context of antipsychotics. The error of using high-dose haloperidol as a comparator in assessments of new antipsychotics—and of generalizing from the results of these studies—is also discussed. The CATIE results force uncomfortable questions about the extent of knowledge concerning the clinical pharmacology of a major treatment modality, which the author illustrates by examining possible reasons for the differential clinical actions of clozapine. The author concludes that CATIE benefited both patients and clinicians by opening up to patients the full gamut of antipsychotics for treatment planning and by reinstating to physicians their key skill in expert, individualized prescribing.


Related Articles:

May 2008: This Month's Highlights
Psychiatr Serv 2008 59: 475. [Full Text] [PDF]

Introduction to the CATIE Special Section
Marvin S. Swartz
Psychiatr Serv 2008 59: 497-499. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
M. S. Swartz
Introduction to the CATIE Special Section
Psychiatr Serv, May 1, 2008; 59(5): 497 - 499.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2008 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org